Skip to main content

and
  1. Article

    Open Access

    Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

    We hypothesized that a gender difference in clinical response may exist to adjuvant CTLA4 blockade with ipilimumab versus high-dose IFNα (HDI). We investigated differences in candidate immune biomarkers in the...

    Mariam Saad, Sandra J. Lee, Aik Choon Tan in Journal of Translational Medicine (2022)